RICT 2024

58th International Conference on Medicinal Chemistry
58èmes Rencontres Internationales de Chimie Thérapeutique

Interfacing Chemical Biology and Drug Discovery

 Bordeaux, France    July 3-5, 2024

Inaugural Lecture

Inaugural Lecture
Toward Universal Druggability (PL01)

Prof. Gregory L. VERDINE
Prof. Gregory L. VERDINE
CO-FOUNDER, PRESIDENT AND CEO LIFEMINE THERAPEUTICS, Cambridge, MA, United States
Read more

Plenary Speakers

Gut Feeling: Illuminating Atypical Stress-sensing Mechanisms in the Gut Empowers New Therapeutic Opportunities (PL06)

Prof. Yimon AYE
Prof. Yimon AYE
ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL), Lausanne, Switzerland
Read more

Synthetic and Medicinal Chemistry for Biologics (PL16)

Prof. Jeffrey BODE
Prof. Jeffrey BODE
ETH ZURICH, Zürich, Switzerland
Read more

Modern Modelling Techniques to Aid Structure-Based Drug Design (PL03)

Dr Massimiliano BONOMI
Dr Massimiliano BONOMI
INSTITUT PASTEUR, Paris, France
Read more

How Degraders Work: Molecular Recognition and Design Principles (PL11)

Prof. Alessio CIULLI
Prof. Alessio CIULLI
UNIVERSITY OF DUNDEE, Dundee, United Kingdom
Read more

Toward a Holistic Drug Discovery Approach - How Chemical Biology & Novel Technologies Support the Identification & Development of Drug Candidates (PL08)

Dr Uwe GRETHER
Dr Uwe GRETHER
F. HOFFMANN-LA ROCHE, Basel, Switzerland
Read more

Expanding the Chemical Toolbox of E3 Ligase Ligands for PROTAC Design (PL12)

Prof. Michael GUTSCHOW
Prof. Michael GUTSCHOW
UNIVERSITY OF BONN, Bonn, Germany
Read more

Advancements in Drug-like Cyclic Peptides: A Pathway to Orally Available KRAS Inhibitor (PL13)

Dr Satoshi HASHIMOTO
Dr Satoshi HASHIMOTO
CHUGAI PHARMACEUTICAL, Kanagawa, Japan
Read more

Title to be announced (PL04)

Prof. Akane KAWAMURA
Prof. Akane KAWAMURA
NEWCASTLE UNIVERSITY, Newcastle, United Kingdom

Title to be announced (PL09)

Dr Angela MACKAY
Dr Angela MACKAY
NOVARTIS PHARMA AG, Basel, Switzerland
Read more

Recent Advances in DNA-Encoded Library Technologies at GSK (PL17)

Dr Lisa MARCAURELLE
Dr Lisa MARCAURELLE
GSK, Cambridge, United States
Read more

The Discovery of a GPCR Antagonist as Clinical Candidate for Autoimmune Diseases (PL14)

Dr Emmanuel MEYER
Dr Emmanuel MEYER
UNIVERSITY OF BASEL, Basel, Switzerland
Read more

Tools and Tactics for Targeting RNA with Small Molecules (PL02)

Dr Jay SCHNEEKLOTH
Dr Jay SCHNEEKLOTH
NATIONAL CANCER INSTITUTE, Frederick, United States
Read more

Vaccines, Antibody Therapies and Diagnostics Based on Synthetic Carbohydrates (PL18)

Prof. Peter H. SEEBERGER
Prof. Peter H. SEEBERGER
MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES, Berlin, Germany
Read more

Exploring PTM Chemical Biology for Drug Discovery (PL07)

Prof. Edward TATE
Prof. Edward TATE
IMPERIAL COLLEGE LONDON, London, United Kingdom
Read more

Molecular Switches for Gene Control (PL05)

Prof. Olalla VÁZQUEZ
Prof. Olalla VÁZQUEZ
PHILIPPS-UNIVERSITÄT MARBURG, Marburg, Germany
Read more

Design, Synthesis and Evaluation of PET Tracers Targeting alpha-Synuclein, a Rational Approach (PL10)

Prof. Bert WINDHORST
Prof. Bert WINDHORST
VU UNIVERSITY MEDICAL CENTER, Amsterdam, The Netherlands
Read more

Short Lectures

Discovering Novel Inhibitors of Wild-type and Acquired Drug-resistant Mutant Forms of c-MET (SL06)

Dr Gavin W. COLLIE
Dr Gavin W. COLLIE
ASTRAZENECA, Cambridge, United Kingdom
Read more

New Modalities Enabling Target Validation (SL03)

Dr Werngard CZECHTIZKY
Dr Werngard CZECHTIZKY
ASTRAZENECA, Mölndal, Sweden
Read more

Cryo-EM at Astrazeneca: Enabling SBDD in Challenging Multiprotein Targets (SL02)

Dr Taiana MAIA DE OLIVEIRA
Dr Taiana MAIA DE OLIVEIRA
ASTRAZENECA PLC, Cambridge, United Kingdom
Read more

Induced-Volatolomics, a New Research Field in Chemical Biology (SL04)

Dr Pauline POINOT
Dr Pauline POINOT
UNIVERSITY OF POITIERS, Poitiers, France
Read more

Discovery of Novel Small Molecules Binders of Soluble Mutant HTT & Derivatization into PROTACs (SL05)

Dr Geoffrey SCHWERTZ
Dr Geoffrey SCHWERTZ
UCB BIOPHARMA, Braine l'Alleud, Belgium
Read more

Small-Molecule Inhibitors of RNA-binding Proteins Regulating m6A RNA Methylation (SL01)

Dr Peng WU
Dr Peng WU
MAX-PLANCK-INSTITUTE OF MOLECULAR PHYSIOLOGY, Dortmund, Germany
Read more